510(k) K914022

SERIOLOGICAL TEST KIT/IGM ANTIBODY VARI-ZOST VIRUS by Pharmacia Diagnostics, Inc. — Product Code LFY

K914022 is an FDA 510(k) premarket notification submitted by Pharmacia Diagnostics, Inc. for the device "SERIOLOGICAL TEST KIT/IGM ANTIBODY VARI-ZOST VIRUS". The FDA issued a decision of Substantially Equivalent on January 27, 1992. The device falls under product code LFY (Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster), a Class II device regulated under 21 CFR 866.3900. Pharmacia Diagnostics, Inc. has at least 8 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 27, 1992
Date Received
September 9, 1991
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster
Device Class
Class II
Regulation Number
866.3900
Review Panel
MI
Submission Type